S Pelliccioni

660 total citations
18 papers, 501 citations indexed

About

S Pelliccioni is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, S Pelliccioni has authored 18 papers receiving a total of 501 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 7 papers in Pulmonary and Respiratory Medicine and 6 papers in Molecular Biology. Recurrent topics in S Pelliccioni's work include Lung Cancer Treatments and Mutations (6 papers), Neuroendocrine Tumor Research Advances (5 papers) and Lung Cancer Research Studies (5 papers). S Pelliccioni is often cited by papers focused on Lung Cancer Treatments and Mutations (6 papers), Neuroendocrine Tumor Research Advances (5 papers) and Lung Cancer Research Studies (5 papers). S Pelliccioni collaborates with scholars based in Italy, Netherlands and Iran. S Pelliccioni's co-authors include Gabriella Fontanini, Greta Alì, Agnese Proietti, Laura Boldrini, Alfredo Mussi, Niccola Funel, Cristina Niccoli, Antonio Chella, Adam E. Frampton and Godefridus J. Peters and has published in prestigious journals such as Journal of Clinical Oncology, Current Pharmaceutical Design and Thyroid.

In The Last Decade

S Pelliccioni

18 papers receiving 492 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
S Pelliccioni Italy 13 240 189 171 168 116 18 501
Michelle Eugeni United States 6 157 0.7× 182 1.0× 102 0.6× 56 0.3× 120 1.0× 10 456
Lu‐Jun Zhao China 13 253 1.1× 142 0.8× 96 0.6× 239 1.4× 126 1.1× 20 517
Francois J. Geoffroy United States 9 285 1.2× 204 1.1× 109 0.6× 180 1.1× 125 1.1× 18 571
Angela Calabrese Italy 10 218 0.9× 113 0.6× 70 0.4× 90 0.5× 54 0.5× 18 376
Huan-Huan Wang China 11 195 0.8× 158 0.8× 100 0.6× 151 0.9× 103 0.9× 13 461
Daniel E. Soto United States 12 169 0.7× 193 1.0× 136 0.8× 203 1.2× 38 0.3× 26 574
Laura July Canada 7 339 1.4× 252 1.3× 141 0.8× 148 0.9× 57 0.5× 9 623
W. Tristram Arscott United States 12 181 0.8× 280 1.5× 157 0.9× 73 0.4× 28 0.2× 20 520
Ludivine Le Dret France 8 90 0.4× 285 1.5× 116 0.7× 104 0.6× 66 0.6× 13 611
Chunhui Zhou China 10 158 0.7× 294 1.6× 176 1.0× 72 0.4× 38 0.3× 29 564

Countries citing papers authored by S Pelliccioni

Since Specialization
Citations

This map shows the geographic impact of S Pelliccioni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S Pelliccioni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S Pelliccioni more than expected).

Fields of papers citing papers by S Pelliccioni

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S Pelliccioni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S Pelliccioni. The network helps show where S Pelliccioni may publish in the future.

Co-authorship network of co-authors of S Pelliccioni

This figure shows the co-authorship network connecting the top 25 collaborators of S Pelliccioni. A scholar is included among the top collaborators of S Pelliccioni based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S Pelliccioni. S Pelliccioni is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Simbolo, Michele, Stefano Barbi, Matteo Fassan, et al.. (2019). Gene Expression Profiling of Lung Atypical Carcinoids and Large Cell Neuroendocrine Carcinomas Identifies Three Transcriptomic Subtypes with Specific Genomic Alterations. Journal of Thoracic Oncology. 14(9). 1651–1661. 73 indexed citations
2.
Alì, Greta, Rossella Bruno, Mauro Savino, et al.. (2018). Analysis of Fusion Genes by NanoString System: A Role in Lung Cytology?. Archives of Pathology & Laboratory Medicine. 142(4). 480–489. 28 indexed citations
3.
Bruno, Rossella, Cristiana Lupi, Lorenza Landi, et al.. (2017). MET exon 14 mutations in advanced lung adenocarcinoma: Frequency and coexisting alterations.. Journal of Clinical Oncology. 35(15_suppl). e20656–e20656. 3 indexed citations
4.
Maftouh, Mina, Amir Avan, Niccola Funel, et al.. (2014). miR-211 Modulates Gemcitabine Activity Through Downregulation of Ribonucleotide Reductase and Inhibits the Invasive Behavior of Pancreatic Cancer Cells. Nucleosides Nucleotides & Nucleic Acids. 33(4-6). 384–393. 54 indexed citations
6.
Boldrini, Laura, Mirella Giordano, Greta Alì, et al.. (2014). P2X7 protein expression and polymorphism in non-small cell lung cancer (NSCLC). Journal of Negative Results in BioMedicine. 13(1). 16–16. 16 indexed citations
7.
Proietti, Agnese, Greta Alì, S Pelliccioni, et al.. (2014). Anaplastic lymphoma kinase gene rearrangements in cytological samples of non–small cell lung cancer: Comparison with histological assessment. Cancer Cytopathology. 122(6). 445–453. 33 indexed citations
8.
Ugolini, Clara, Rossella Elisei, Agnese Proietti, et al.. (2013). FoxP3 Expression in Papillary Thyroid Carcinoma: A Possible Resistance Biomarker to Iodine 131 Treatment. Thyroid. 24(2). 339–346. 23 indexed citations
9.
Alì, Greta, Agnese Proietti, Cristina Niccoli, et al.. (2013). EML4-ALK translocation in both metachronous second primary lung sarcomatoid carcinoma and lung adenocarcinoma: A case report. Lung Cancer. 81(2). 297–301. 10 indexed citations
10.
Capodanno, Alessandra, Laura Boldrini, Agnese Proietti, et al.. (2013). Let-7g and miR-21 expression in non-small cell lung cancer: Correlation with clinicopathological and molecular features. International Journal of Oncology. 43(3). 765–774. 47 indexed citations
11.
Borrelli, Nicla, Riccardo Giannini, Agnese Proietti, et al.. (2013). KIF5B/RET fusion gene analysis in a selected series of cytological specimens of EGFR, KRAS and EML4-ALK wild-type adenocarcinomas of the lung. Lung Cancer. 81(3). 377–381. 8 indexed citations
12.
Alì, Greta, Nicla Borrelli, Riccardo Giannini, et al.. (2013). Differential Expression of Extracellular Matrix Constituents and Cell Adhesion Molecules between Malignant Pleural Mesothelioma and Mesothelial Hyperplasia. Journal of Thoracic Oncology. 8(11). 1389–1395. 19 indexed citations
13.
Capodanno, Alessandra, Laura Boldrini, Greta Alì, et al.. (2012). Phosphatidylinositol-3-kinase α catalytic subunit gene somatic mutations in bronchopulmonary neuroendocrine tumours. Oncology Reports. 28(5). 1559–1566. 17 indexed citations
14.
Avan, Amir, Karl Quint, Francesco Nicolini, et al.. (2012). Enhancement of the Antiproliferative Activity of Gemcitabine by Modulation of c-Met Pathway in Pancreatic Cancer. Current Pharmaceutical Design. 19(5). 940–950. 2 indexed citations
15.
Avan, Amir, Karl Quint, Niccola Funel, et al.. (2012). Enhancement of the Antiproliferative Activity of Gemcitabine by Modulation of c-Met Pathway in Pancreatic Cancer. Current Pharmaceutical Design. 19(5). 940–950. 52 indexed citations
16.
Avan, Amir, Karl Quint, Francesco Nicolini, et al.. (2012). Enhancement of the Antiproliferative Activity of Gemcitabine by Modulation of c-Met Pathway in Pancreatic Cancer. Current Pharmaceutical Design. 19(5). 940–950. 2 indexed citations
17.
Alì, Greta, Laura Boldrini, Alessandra Capodanno, et al.. (2011). Expression of p-AKT and p-mTOR in a large series of bronchopulmonary neuroendocrine tumors. Experimental and Therapeutic Medicine. 2(5). 787–792. 21 indexed citations
18.
Vittorio, Orazio, Paola Quaranta, Vittoria Raffa, et al.. (2010). Magnetic Carbon Nanotubes: A New Tool for Shepherding Mesenchymal Stem Cells by Magnetic Fields. Nanomedicine. 6(1). 43–54. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026